Procept BioRobotics Corp (NASDAQ: PRCT) kicked off on Monday, up 5.18% from the previous trading day, before settling in for the closing price of $92.29. Over the past 52 weeks, PRCT has traded in a range of $27.65-$99.34.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 142.74%. While this was happening, its average annual earnings per share was recorded 21.48%. With a float of $48.95 million, this company’s outstanding shares have now reached $50.77 million.
Considering the fact that the conglomerate employs 626 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 56.09%, operating margin of -53.27%, and the pretax margin is -50.07%.
Procept BioRobotics Corp (PRCT) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of Procept BioRobotics Corp is 5.74%, while institutional ownership is 84.85%. The most recent insider transaction that took place on Oct 30 ’24, was worth 26,249,951. In this transaction President, CEO of this company sold 288,461 shares at a rate of $91.00, taking the stock ownership to the 258,445 shares. Before that another transaction happened on Oct 15 ’24, when Company’s EVP, CFO sold 25,000 for $72.47, making the entire transaction worth $1,811,653. This insider now owns 96,096 shares in total.
Procept BioRobotics Corp (PRCT) Earnings and Forecasts
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.54 earnings per share (EPS), lower than consensus estimate (set at -0.44) by -0.1. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.39 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 21.48% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 23.10% during the next five years compared to -23.27% drop over the previous five years of trading.
Procept BioRobotics Corp (NASDAQ: PRCT) Trading Performance Indicators
Take a look at Procept BioRobotics Corp’s (PRCT) current performance indicators. Last quarter, stock had a quick ratio of 5.07. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 26.42.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.95, a number that is poised to hit -0.35 in the next quarter and is forecasted to reach -1.38 in one year’s time.
Technical Analysis of Procept BioRobotics Corp (PRCT)
Compared to the last year’s volume of 0.65 million, its volume of 1.56 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 81.04%. Additionally, its Average True Range was 5.24.
During the past 100 days, Procept BioRobotics Corp’s (PRCT) raw stochastic average was set at 94.99%, which indicates a significant increase from 93.08% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 122.97% in the past 14 days, which was higher than the 73.62% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $78.01, while its 200-day Moving Average is $62.67. Nevertheless, the first resistance level for the watch stands at $99.63 in the near term. At $102.20, the stock is likely to face the second major resistance level. The third major resistance level sits at $106.06. If the price goes on to break the first support level at $93.20, it is likely to go to the next support level at $89.34. Should the price break the second support level, the third support level stands at $86.77.
Procept BioRobotics Corp (NASDAQ: PRCT) Key Stats
The company with the Market Capitalisation of 5.28 billion has total of 52,183K Shares Outstanding. Its annual sales at the moment are 136,190 K in contrast with the sum of -105,900 K annual income. Company’s last quarter sales were recorded 53,350 K and last quarter income was -25,630 K.
